Work

A phase II study of sacituzumab govitecan for advanced esophageal squamous cell carcinoma patients (SG-ESCC).

Year: 2025

Type: conference-abstract

Study design: Study Protocol

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.tps4208

Authors: Jhe-Cyuan Guo, Tsung-Che Wu, Ta-Chen Huang, Hung-Yang Kuo, Chien-Huai Chuang, Wei-Chen Lu, Chia-Chi Lin, Chih-Hung Hsu

Institutions: National Taiwan University, National Taiwan University Hospital

Language: English

Topic: Esophageal Cancer Research and Treatment

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410814809

Cites:

Cited by: 1

Related to: 10